AzTrials
AzTrials

ContraceptionCARENCT01132950

Contraceptive Awareness and Reproductive Education

A study testing Motivational Interviewing and Didactic Educational Counseling in people with Contraception and Sexually Transmitted Diseases, run by Memorial Hospital of Rhode Island at 2 sites in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to increase the initiation and continuation of highly effective contraceptive use while incarcerated and upon release, as well as decrease unsafe sexual activity. Read more about this study

Who is it for?
Ages 18 to 35 years, women onlyHealthy volunteers can take part
What is being tested?
Motivational Interviewing and Didactic Educational Counseling
Could I receive a placebo?
No, everyone receives an active treatment
How many people
400 participants
Where
2 sitesUnited States
Study dates
Feb 2009to Jun 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age 18-35;
  • Currently sexually active with men defined as having coital sex at least monthly in the past three non-institutionalized months;
  • Expected place of residence after release in Providence County or within 15 miles of follow-up site;
  • Willing to comply with protocol, follow-up and provide at least one locator;
  • Fluent in English.

Who cannot join

  • Inability to give informed consent secondary to organic brain dysfunction, not having own legal guardianship, or active psychosis or otherwise not able to participate in the intervention or assessments (deaf, blind, or impaired communication skills that impair ability to participate in computerize assessment or counseling);
  • Pregnant or trying to become pregnant within the next year;
  • Hysterectomy, bilateral oophorectomy, tubal ligation, IUD or Essure (coil), implantable contraceptive devices (Implanon) or other procedures which make it very unlikely to become pregnant;
  • Women who are monogamous for more than one year whose partner has had a vasectomy;
  • Housed in segregation as we will be unable to recruit them for the study

Trial locations and contacts

2 sites in 1 country.

Jennifer G Clarke, MD, MPH contact

401-729-3400

Jennifer_Clarke@mhri.org

Jennifer A Mello, MPH contact

401-729-3573

Jennifer_Mello@mhri.org

United States2 sites, 2 recruiting
  • Memorial Hospital of Rhode Island

    Pawtucket, Rhode Island, 02860

    Jennifer G Clarke, MD, 401-729-3400, Jennifer_Clarke@mhri.org

    Jennifer A Mello, MPH, 401-729-3573, Jennifer_Mello@mhri.org

    Recruiting
  • Memorial Hospital of Rhode Island

    Pawtucket, Rhode Island, 02860

    Recruiting

Other trials in United States

About this study

Official title: Empowering Women to Make Contraceptive Choices While Incarcerated

The purpose of this study is to increase the initiation and continuation of highly effective contraceptive use while incarcerated and upon release, as well as decrease unsafe sexual activity.

Read the detailed description

Unplanned pregnancies and sexually transmitted infections are important and costly public health problems in the United States resulting from unprotected sexual activity. Women with a history of incarceration are at increased risk for these problems given the high rates of substance abuse and commercial sex work in this population. This proposal is designed to evaluate an innovative intervention Motivational Interviewing with Computer Assistance (MICA) designed to improve contraceptive use for incarcerated women who do not want a pregnancy and are soon to be released into the community. The investigators will utilize the Title X program which, in conjunction with RI Department of Corrections (RI DOC), provides reproductive health services in jail and then transitional services in the community after release. The investigators plan to recruit 400 women from the RI DOC women's jail and randomize them to two interventions: two sessions of personalized MICA or two sessions of Didactic Educational Counseling (DEC), both delivered individually by trained counselors. The two counseling interventions will be similar in length and timing, but will vary in content, counseling style and the individualized computer generated feedback that is reviewed with the counselor.

Being tested
Motivational Interviewing, Didactic Educational Counseling
Medical subject headings
Sexually Transmitted Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Motivational InterviewingBehavioural

    Two personalized sessions of motivational interviewing. The first one is given while the participant is in jail and the second one is given at 3 months post release.

  • Didactic Educational CounselingOther

    Participant will watch an educational video while in jail and a second educational video at 3 months post release.

Study groups in NCT01132950
Study groupRoleWhat they receive
Didactic Educational CounselingActive comparatorNot described
Receives: Other: Didactic Educational Counseling
Motivation InterviewingExperimentalParticipant will receive two sessions of personalized motivational interviewing.
Receives: Behavioral: Motivational Interviewing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Contraceptive initiation

    Initiation of a highly effective contraceptive method prior to release from jail will be limited to methods that are 98% or more effective in preventing pregnancy (Table 1).41 Initiation of these methods will be verified through review of the RI DOC medical records (as we have done in the past).

    Measured: 5 years

  2. Continuous use of highly effective contraceptives at follow-up

    If a participant switches from one highly effective contraceptive method to another she will be recorded as maintaining continuous contraceptive use at follow-up if she switches methods during times when the original method is still effective. Use of contraceptive methods will be confirmed through both TLFB and medical record review.

    Measured: 5 years

  3. Incident STIs

    At baseline participants will be tested for T. vaginalis, N. gonorrhoeae, and C. trachomatis through self obtained vaginal swabs. If a participant is diagnosed with an STI at baseline she will be treated and she will be asked to follow-up in six weeks for a test for cure. Any positive test after a baseline negative test will be documented as an incident infection.

    Measured: 5 years

Secondary outcomes (2)
  1. Incident pregnancy

    An incident pregnancy will be defined as having occurred if there is a baseline negative pregnancy test and a positive urine Beta-HCG test through the study or a self reported pregnancy confirmed with a positive urine or serum Beta-hCG test through medical record review during the time of study participation. If a participant reports a positive pregnancy test outside of the study then she will be asked to sign a release of medical information form and a copy of the test results will be obtained.

    Measured: 5 years

  2. Risk for unintended pregnancy and STIs

    Risk behaviors will be determined through the TLFB. No or low risk for an unintended pregnancy will include either continuous use of a highly effective contraceptive method, abstinence, or use of a condom with a spermicide during every act of intercourse. No or low risk for STIs include abstinence or use of a condom with every act of intercourse and with every partner.

    Measured: 5 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 May 2010 (estimated)
  2. Study startFeb 2009
  3. Primary completionJun 2012 (estimated)
  4. Study completionJun 2013 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01132950
Sponsor's protocol ID
CARE 07-42
Other IDs
5R01HD054890
Acronym
CARE
Status last verified
Sep 2010
First submitted
27 May 2010
Last updated
9 Sep 2010
Results posted
No
Data monitoring committee
No

Publications

  • Clarke J, Gold MA, Simon RE, Roberts MB, Stein L. Motivational interviewing with computer assistance as an intervention to empower women to make contraceptive choices while incarcerated: study protocol for randomized controlled trial. Trials. 2012 Jul 2;13:101. doi: 10.1186/1745-6215-13-101.

    PubMed 22747705

Questions about this trial

What is this clinical trial studying?

A study testing Motivational Interviewing and Didactic Educational Counseling in people with Contraception and Sexually Transmitted Diseases, run by Memorial Hospital of Rhode Island at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Sep 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jennifer G Clarke, MD, MPH (401-729-3400, Jennifer_Clarke@mhri.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Contraceptive initiation (time frame: 5 years). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01132950, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in